The oncological relevance of fragile sites in cancer
- PMID: 33980983
- PMCID: PMC8115686
- DOI: 10.1038/s42003-021-02020-5
The oncological relevance of fragile sites in cancer
Abstract
Recent developments in sequencing the cancer genome have provided the first in-depth mapping of structural variants (SV) across 38 tumour types. Sixteen signatures of structural variants have been proposed which broadly characterise the variation seen across cancer types. One signature shows increased duplications and deletions at fragile sites, with little association with the typical DNA repair defects. We discuss how, for many of these fragile sites, the clinical impacts are yet to be explored. One example is NAALADL2, one of the most frequently altered fragile sites in the cancer genome. The copy-number variations (CNVs) which occur at fragile sites, such as NAALADL2, may span many genes without typical DNA repair defects and could have a large impact on cell signalling.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8115686/bin/42003_2021_2020_Fig1_HTML.gif)
Similar articles
-
Signatures of mutation and selection in the cancer genome.Nature. 2010 Feb 18;463(7283):893-8. doi: 10.1038/nature08768. Nature. 2010. PMID: 20164919 Free PMC article.
-
Fragile sites in cancer: more than meets the eye.Nat Rev Cancer. 2017 Jul 25;17(8):489-501. doi: 10.1038/nrc.2017.52. Nat Rev Cancer. 2017. PMID: 28740117 Free PMC article. Review.
-
An Evolutionary Perspective on the Impact of Genomic Copy Number Variation on Human Health.J Mol Evol. 2020 Jan;88(1):104-119. doi: 10.1007/s00239-019-09911-6. Epub 2019 Sep 14. J Mol Evol. 2020. PMID: 31522275 Review.
-
Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.Sci Rep. 2020 Oct 14;10(1):17199. doi: 10.1038/s41598-020-74276-6. Sci Rep. 2020. PMID: 33057153 Free PMC article.
-
Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response.PLoS Genet. 2016 Dec 15;12(12):e1006436. doi: 10.1371/journal.pgen.1006436. eCollection 2016 Dec. PLoS Genet. 2016. PMID: 27977694 Free PMC article. Review.
Cited by
-
Optical genome mapping unveils hidden structural variants in neurodevelopmental disorders.Sci Rep. 2024 May 16;14(1):11239. doi: 10.1038/s41598-024-62009-y. Sci Rep. 2024. PMID: 38755281 Free PMC article.
-
Deciphering the role of non-coding RNAs involved in sorafenib resistance.Heliyon. 2024 Apr 13;10(8):e29374. doi: 10.1016/j.heliyon.2024.e29374. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38644890 Free PMC article.
-
Pulsed Electromagnetic Fields (PEMFs) Trigger Cell Death and Senescence in Cancer Cells.Int J Mol Sci. 2024 Feb 20;25(5):2473. doi: 10.3390/ijms25052473. Int J Mol Sci. 2024. PMID: 38473720 Free PMC article.
-
Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.Cancer Res. 2024 Apr 1;84(7):1013-1028. doi: 10.1158/0008-5472.CAN-22-3219. Cancer Res. 2024. PMID: 38294491 Free PMC article.
-
Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma.Clin Transl Med. 2024 Jan;14(1):e1556. doi: 10.1002/ctm2.1556. Clin Transl Med. 2024. PMID: 38279874 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources